Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification
Diagnostics · 24.06.2025 · 15 (13) · 1599
DOI: 10.3390/diagnostics15131599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 24.06.2025. Verfasst von Hyukjin Yoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Catholic Medical Center Research Foundation.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the consistency of Centiloid (CL) values calculated using three commercially available software platforms: BTXBrain (v1.1.2), MIM (v7.3.7), and SCALE PET (v2.0.1).
Methods
A total of 239 patients who underwent amyloid PET/CT with either F-18 flutemetamol (FMM) or F-18 florbetaben (FBB) were retrospectively analyzed. CL values were calculated using BTXBrain, MIM, and SCALE PET. Linear regression, Passing–Bablok regression, and Bland–Altman analysis were performed to assess the agreement between CL values. Subgroup analyses were conducted for each radiotracer. CL values were compared according to visual interpretation status.
Results
Strong correlations were observed between CL values derived from the three software platforms (R2 > 0.95). However, Passing–Bablok regression revealed significant proportional bias, with CL values from BTXBrain being lower than others, and CL values from SCALE PET being higher than others as CL values increased. Bland–Altman plots visualized the proportional bias, particularly between BTXBrain and SCALE PET. Subgroup analyses by radiotracer showed similar results. CL values in visually positive scans were significantly higher than those in visually negative scans across all platforms.
Conclusions
The three commercial software programs demonstrated high consistency in CL quantification. However, a notable systematic bias was observed. Further evaluation of various scanner effects and CL calculation methods is warranted to improve the consistency and reproducibility of CL quantification in clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nuclear Medicine, Department of Radiology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
- Department of Psychiatry, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
ORCID-Profile: Hyukjin Yoon, Narae Lee, Yoo Hyun Um, Woo Hee Choi
Förderung
- National Research Foundation of Korea
- Catholic Medical Center Research Foundation
Zitieren
APA
Yoon, H., Lee, N., Um, Y. H., & Choi, W. H. (2025). Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification. Diagnostics, 15(13), 1599. https://doi.org/10.3390/diagnostics15131599
Vancouver
Yoon H, Lee N, Um YH, Choi WH. Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification. Diagnostics. 2025;15(13):1599. doi:10.3390/diagnostics15131599
BibTeX
@article{Yoon2025,
author = {Yoon, Hyukjin and Lee, Narae and Um, Yoo Hyun and Choi, Woo Hee},
title = {Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {13},
pages = {1599},
doi = {10.3390/diagnostics15131599}
}
EUVIMED